Clinicians are advised to be vigilant following Australian research showing that cytomegalovirus (CMV) infection or disease is common in patients with haematological malignancies outside the haematopoietic cell transplant setting. A retrospective review of patients with haematological and solid organ cancers at the Peter MacCallum Cancer Centre between 2013 and 2020 found 25% of 953 patients ...
Blood cancer patients at risk from CMV beyond HCT setting
By Mardi Chapman
9 Sep 2021